Company Filing History:
1 out of 1 
1 out of 723 Years Active: 1999
Title: Innovator Simon M Temperley: Pioneering Protein C Production in Transgenic Mammals
Introduction: Simon M Temperley is a distinguished inventor based in Edinburgh, GB, whose groundbreaking contributions to biotechnology focus on the production of protein C in non-human transgenic mammals. His innovative approaches in this field have implications for medical advancements, particularly in anticoagulant therapies.
Latest Patents: Simon M Temperley holds a notable patent for "Protein C production in non-human transgenic mammals." This patent discloses methods for producing modified protein C by introducing DNA segments encoding this protein into the germ line of non-human mammals. The engineered mammals or their female progeny can produce milk containing the expressed protein C, which exhibits significant anticoagulant activity upon activation. The modification involves altering the cleavage site of protein C to enhance its functionality.
Career Highlights: Throughout his career, Temperley has worked with several prominent companies in the biopharmaceutical sector, including PPL Therapeutics and ZymoGenetics, Inc. His work at these companies has been instrumental in pushing the boundaries of genetic engineering and protein synthesis.
Collaborations: Simon has collaborated with notable colleagues in his field, such as Ian Garner and Ian Robert Cottingham. These partnerships have facilitated the advancement of research and development processes in the innovative production of therapeutic proteins.
Conclusion: Simon M Temperley's contributions to the field of biotechnology, particularly through his patented methods for protein C production in transgenic mammals, highlight his role as a leader in innovation. His successful career and collaborations with esteemed professionals reflect the importance of teamwork in achieving significant scientific breakthroughs.